November 2016 - Proteome Sciences Appointment



IFC is very pleased to have been appointed by AIM quoted Proteome Sciences (AIM:PRM) to deliver Financial Public Relations and Investor Relations services. Based in Cobham, Proteome is a leader in applied proteomics offering high sensitivity, proprietary technologies and workflows for mapping cell signalling pathways (SysQuant® , TMTcalibratorTM) and for the discovery, validation and assay development of protein biomarkers.

Proteome has patented a number of novel protein biomarkers for diagnostic and treatment applications in important areas of human therapeutics such as cancer, stroke and Alzheimer's disease, and these are available for license.